Trials

University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.

It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.

  • E7080 HCC

    A Multicenter Randomized Open-Label Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-Line Treatment of Subjects With Unresectable Hepatocellular Carcinoma

    View Trial
  • WIN TAVI

    Women’s INternational Transcatheter Aortic Valve Implantation Registry

    View Trial
  • CO-RADAR

    Commensal Organisms & Rapid Diagnosis of Ocular Infections (CO-RADAR)

    View Trial
  • Use of venesected blood from patients with haemochromatosis to isolate and culture lmmune cells

    View Trial
  • UKPID registry

    UK Version of the ESID on-line Registry

    View Trial
  • FOCUS4

    FOCUS4 – Molecular selection of therapy in colorectal cancer: a molecularly stratified randomised controlled trials programme

    View Trial
  • Hemianopia

    Using MRI to investigate changes in connectivity structure and function in patients with cortical visual damage

    View Trial
  • National guidance for measuring home furniture and fittings to enable user self-assessment and successful fit of minor assistive devices

    View Trial
  • Adjuvant peginterferon alfa-2b for 2 years vs Observation in patients with an ulcerated primary cutaneous melanoma with T(2-4)bN0M0: A randomized phase III trial of the EORTC Melanoma Group

    View Trial
  • TWICS

    A randomised double-blind placebo controlled trial of the effectiveness of low dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease

    View Trial